Description: Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Home Page: www.chipscreen.com
Biology Incubator Building 2
Shenzhen,
518057
China
Phone:
86 75 5269 57330
Officers
| Name | Title |
|---|---|
| Dr. Xian-Ping Lu | Founder, Chairman, GM, CEO & Pres |
| Dr. Zhiqiang Ning M.D., Ph.D. | Co-Founder, VP, Deputy GM and Head of Clinical R&D |
| Mr. Jian-Xun Li BA.CFA | VP, Deputy GM, CFO & Director |
| Dr. Desi Pan | VP, Deputy GM, Chief Scientific Officer and Head of the Early R&D Center |
| Ms. Ou Hai | VP, Deputy GM, Sec. of the Board, Head of Legal & Intellectual Property Department and Director |
| Ms. Shumei Zhao BS. | VP, Deputy GM and Head of Brand & Public Affairs Department |
| Dr. Zhi-Bin Li Ph.D. | VP, Deputy GM and Head of Product Devel. & Production |
| Mr. Liangji She | VP, Deputy GM & Head of Oncology Division |
| Mr. Libin Zhang | VP, Deputy GM & Head of Metabolic Diseases Division |
| Dr. Leming Shi | Co-Founder |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 2416 |
| Price-to-Book MRQ: | 5.9745 |
| Price-to-Sales TTM: | 19.3192 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 909 |